Live from the NIH registry
Studies recruiting near Killeen right now
Top 25 of 106 recruiting studies, sorted by proximity — each links to its official registry page
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Heart Failure (HF)
N/A
Interventional 420 participants sought
Baylor Scott & White Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Aventusoft, LLC.
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
Baylor Scott and White Mclane Children's — Belton, Texas (15.8 mi)
· Sponsor: Seattle Children's Hospital
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: SWOG Cancer Research Network
A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for Veterans With PTSD
Posttraumatic Stress Disorder
N/A
Interventional 250 participants sought
Central Texas Veterans Health Care System, Temple, TX — Temple, Texas (22.9 mi)
· Sponsor: VA Office of Research and Development
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG
Phase 2
Interventional 254 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Fore Biotherapeutics
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Baylor Scott & White Health — Temple, Texas (22.9 mi)
· Sponsor: Hoffmann-La Roche
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Baylor Scott and White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 3
Interventional 486 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: NRG Oncology
rTMS-augmented Written Exposure Therapy for PTSD
Post Traumatic Stress Disorder
N/A
Interventional 98 participants sought
Central Texas Veterans Health Care System, Temple, TX — Temple, Texas (22.9 mi)
· Sponsor: VA Office of Research and Development
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Radiance Clinical Research - Lampasas - West Avenue East- Site Number : 8400063 — Lampasas, Texas (26.8 mi)
· Sponsor: Sanofi
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 351 participants sought
Baylor Scott and White Medical Center Temple — Temple, Texas (22.9 mi)
· Sponsor: BeOne Medicines
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Temple, Texas (22.9 mi)
· Sponsor: Massive Bio, Inc.
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
Posttraumatic Stress Disorder (PTSD), Suicidal Ideation
N/A
Interventional 190 participants sought
Carl R. Darnall Army Medical Center — Fort Hood, Texas (12.5 mi)
· Sponsor: Ohio State University
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Cancer, Immunotherapy
N/A
Observational 2,000 participants sought
Baylor Scott and White Biorepository — Temple, Texas (22.9 mi)
· Sponsor: Elephas
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Hypertriglyceridemia, Severe Hypertriglyceridemia
Phase 2
Interventional 72 participants sought
Ionis Investigative Site — Lampasas, Texas (26.8 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Chronic Myelogenous Leukemia - Chronic Phase
N/A
Observational 1,000 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Baylor Scott & White - Temple — Temple, Texas (22.9 mi)
· Sponsor: Alleviant Medical, Inc.
Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children
PTSD, Depression
N/A
Interventional 120 participants sought
Steven A. Cohen Military Family Clinic at Endeavors, Killeen — Killeen, Texas (2.9 mi)
· Sponsor: New York University
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Temple, Texas (22.9 mi)
· Sponsor: AstraZeneca
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Radiance Clinical Research — Lampasas, Texas (26.8 mi)
· Sponsor: Novo Nordisk A/S
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Chronic Pain
N/A
Observational 2,000 participants sought
Central Texas Pain Institute — Killeen, Texas (2.9 mi)
· Sponsor: Abbott Medical Devices